Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.22.1
Earnings Per Share (Tables)
9 Months Ended
Mar. 31, 2022
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Quarter Ended

​

Nine Months Ended

​

​

March 31, 

​

March 31, 

​

    

2022

    

2021

​

2022

    

2021

Earnings per share – basic:

​

​

​

​

​

​

​

​

​

​

​

​

Net earnings, including noncontrolling interest

​

$

60,144

 

$

45,402

​

$

201,184

 

$

124,941

Less net earnings (loss) attributable to noncontrolling interest

​

​

(595)

 

​

(380)

​

​

(9,343)

 

​

(509)

Net earnings attributable to Bio-Techne

​

$

60,739

​

$

45,782

​

$

210,527

​

$

125,450

Income allocated to participating securities

​

 

(25)

​

 

(27)

​

 

(95)

​

 

(77)

Income available to common shareholders

​

$

60,714

​

$

45,755

​

$

210,432

​

$

125,373

Weighted-average shares outstanding – basic

​

 

39,272

​

 

38,856

​

 

39,225

​

 

38,693

Earnings per share – basic

​

$

1.55

​

$

1.18

​

$

5.36

​

$

3.24

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share – diluted:

​

 

  

​

 

  

​

 

  

​

 

  

Net earnings, including noncontrolling interest

​

$

60,144

​

$

45,402

​

$

201,184

​

$

124,941

Less net earnings (loss) attributable to noncontrolling interest

​

​

(595)

​

​

(380)

​

​

(9,343)

​

​

(509)

Net earnings attributable to Bio-Techne

​

$

60,739

​

$

45,782

​

$

210,527

​

$

125,450

Income allocated to participating securities

​

 

(25)

​

 

(27)

​

 

(95)

​

 

(77)

Income available to common shareholders

​

$

60,714

​

$

45,755

​

$

210,432

​

$

125,373

Weighted-average shares outstanding – basic

​

 

39,272

​

 

38,856

​

 

39,225

​

 

38,693

Dilutive effect of stock options and restricted stock units

​

 

1,697

​

 

1,820

​

 

1,848

​

 

1,612

Weighted-average common shares outstanding – diluted

​

 

40,969

​

 

40,676

​

 

41,073

​

 

40,305

Earnings per share – diluted

​

$

1.48

​

$

1.12

​

$

5.12

​

$

3.11